Shujing Zhang
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)Beijing Tongren Hospital(CN)Beijing University of Chinese Medicine(CN)Southern University of Science and Technology(CN)Lanzhou Veterinary Research Institute(CN)First Affiliated Hospital of Xi'an Jiaotong University(CN)Zhejiang Lab(CN)Zhejiang University(CN)
Publications by Year
Research Areas
Tryptophan and brain disorders, Dermatology and Skin Diseases, Healthcare and Venom Research, Legal and Regulatory Analysis, Linguistic, Cultural, and Literary Studies
Most-Cited Works
- → Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study(2020)338 cited
- → Development and validation of a risk factor-based system to predict short-term survival in adult hospitalized patients with COVID-19: a multicenter, retrospective, cohort study(2020)99 cited
- → Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease(2019)87 cited
- → The Phenolic Fraction of Mentha haplocalyx and Its Constituent Linarin Ameliorate Inflammatory Response through Inactivation of NF-κB and MAPKs in Lipopolysaccharide-Induced RAW264.7 Cells(2017)62 cited
- → Salvianolic acid B prevents body weight gain and regulates gut microbiota and LPS/TLR4 signaling pathway in high-fat diet-induced obese mice(2020)61 cited
- →